Features | Partner Sites | Information | LinkXpress
Sign In
Ettin Group
Ampronix
Schiller

Implantable Clip Improves Heart Function and Quality of Life

By HospiMedica International staff writers
Posted on 12 Nov 2013
Image: The MitraClip clip delivery system (Photo courtesy of Abbott Vascular).
Image: The MitraClip clip delivery system (Photo courtesy of Abbott Vascular).
A new implantable clip helps patients suffering from degenerative mitral regurgitation who have a prohibitively high risk of complications from open-heart mitral valve surgery.

The MitraClip sytem includes three components: an 8 mm (24F) steerable guide catheter for percutaneous venous access; a clip delivery system that includes the implant attached to a highly maneuverable delivery catheter, with all controls at the proximal end; and the MitraClip device itself, a 4 mm-wide cobalt-chromium clip that is coated in polyester to promote tissue growth. The clip clamps to the mitral valve's two edges, holding them together. Since the heart beats normally during the procedure, the procedure does not require a heart-lung bypass machine.

Among the benefits of the device are a positive safety profile, reduction in mitral regurgitation, favorable left ventricular remodeling, improvement in patient symptoms, and reduction in hospitalizations for heart failure (HF). The clip can be used is magnetic resonance imaging (MRI) systems with a magnet strength of up to 3 Tesla. The MitraClip sytem is a product of Abbott Vascular (Abbott Park, NJ, USA), and has been approved by the US Food and Drug Administration (FDA).

“FDA approval of MitraClip marks an important milestone for Abbott as we continue to bring forward innovative therapies to help patients live better lives,” said Chuck Foltz, senior vice president of Abbott Vascular. “We look forward to making this technology available to specialized centers in the US with multidisciplinary teams experienced in the management of patients with heart valve disease, a model that facilitates dialogue across physician specialties and provides patients with the best treatment outcomes."

“As cardiac surgeons, we see patients with severe mitral regurgitation who we can technically operate on but who are just too frail or sick to survive mitral valve surgery with a reasonable risk and quality of life,” said Michael Mack, MD, director of cardiovascular research and surgery at Baylor Health Care System (Dallas, TX, USA). “With the MitraClip system, heart teams now have a catheter-based, less-invasive treatment option that can help patients who cannot withstand surgery regain their quality of life.”

Related Links:

Abbott Vascular



ACEM
ECR
Cincinnati Sub-Zero

Channels

Critical Care

view channel
Image: The energy harvesting device sutured directly onto the myocardium (Photo courtesy of Adrian Zurbuchen / University of Bern).

Heart Motion Powers Novel Cardiac Pacemaker

A prototype batteryless pacemaker is based on an automatic wristwatch winding movement, with all unnecessary parts removed to reduce weight and size. Developed by Adrian Zurbuchen, a PhD candidate in... Read more

Women's Health

view channel

Aspirin Reduces Breast Cancer Recurrence in Overweight Women

The recurrence of hormone-related breast cancer was reduced by more than half in overweight and obese women who regularly used nonsteroidal anti-inflammatory drugs (NSAIDs), according to a new study. Researchers at the University of Texas (UT; Austin, USA) conducted a retrospective review of data from 440 women with... Read more

Business

view channel

Lloyds Bank Establishes Specialist Healthcare Teams

As part of a substantial restructure, Lloyds Bank Commercial Banking (London, United Kingdom) has launched two specialist healthcare relationship teams. Designated part of the small and medium enterprise (SME) commercial banking division, the two teams will offer industry-specific support for firms in London (United Kingdom).... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.